Home Podcasts USF Health’s IDPodcasts
USF Health’s IDPodcasts

USF Health’s IDPodcasts

IDPodcasts 332 Episodes Aug 10, 2026

USF Health’s IDPodcasts is a collection of infectious diseases podcasts from the University of South Florida Health. The episodes feature educational presentations aimed at healthcare professionals, medical students, residents, and other clinicians. Topics cover a range of infectious disease issues and clinical updates. For more details, visit IDPodcasts.net.

Episodes

What To Do With a Positive Blood Culture
What To Do With a Positive Blood Culture Aug 10, 2026 00:58:26 Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases/USF Morsani College of Medicine, presents a review of bacteremia. Dr. Oehler begins by reviewing the epidemiology, personal and institutional costs of bacteremia. He then discusses blood culture collection and how false positive blood cultures occur. Next, Dr. Oehler reviews automated blood culture systems and mult
Infections in Hematologic Malignancies and Stem Cell Transplantation
Infections in Hematologic Malignancies and Stem Cell Transplantation Aug 4, 2026 01:21:26 Dr. Olga Klinkova, Infectious Diseases Physician at the Moffitt Cancer Center and Research Institute, presents an introductory session on the management of the immunocompromised patient. Dr. Klinkova begins by explaining the major immune deficits in patients with hematologic malignancy and stem cell transplantation (SCT). She then outlines the likely pathogens that produce infections based on th
Microbiology 101
Microbiology 101 Jul 21, 2026 00:58:20 Dr. Suzane Silbert, Director of Tampa General Hospital’s Microbiology laboratory, presents an introductory lecture on the modern infectious diseases laboratory. Topics covered include basic microorganism classification schemes, basic microscopy, E tests, culture techniques, mass spectroscopy, PCR assays, and other molecular technology. Syndromic multiplex panels are also mentioned. The lect
ID Board Review: Peds, Pregnancy, Parasites, Protozoa and Prophylaxis
ID Board Review: Peds, Pregnancy, Parasites, Protozoa and Prophylaxis Jul 2, 2026 00:55:01 Dr. Shylah Moore-Pardo, associate program director of the ID fellowship program at the Morsani College of Medicine, conducts this interactive board review suitable for Medical Students, Residents, and Fellows. Five different categories of questions are covered.
Candida Infections Board Review
Candida Infections Board Review Jun 12, 2026 00:53:59 Dr. Olga Klinkova, Infectious Diseases clinician at Moffitt Cancer Center and Research Institute, conducts a board review session on Candida Infections targeted towards the medical resident or Infectious Diseases Fellow. Topics discussed include a comparison and contrast of the different Candida species, information on Candida auris, Candidemia, and disseminated (hepatosplenic) candidiasis. Also d
Antimicrobial Side Effects: The Zebras, Not the Horses
Antimicrobial Side Effects: The Zebras, Not the Horses Jun 8, 2026 00:36:21 Dr. Yanina Pasikhova, Infectious Diseases Pharmacist at Moffitt Cancer Center and Research Institute, presents a talk on three lesser well known adverse drug effects involving antimicrobials. Dr. Pasikhova discusses the link between voriconazole and bone pain, the association between posaconazole and refractory hypertension and hypokalemia, and the neurological effects of of metronidazole therapy
Rickettsial Infections
Rickettsial Infections May 22, 2026 00:44:28 Dr. Medaris, Chief of Infectious Diseases at Bay Pines Medical Center in St. Petersburg, Florida, conducts a review of Rickettsial Infections. After starting with an overview of the genus Rickettsia, Dr. Medaris moves on to discuss Rocky Mountain Spotted Fever, R. Parkeri, Mediterranean Spotted Fever, and Rickettsial Pox. African Tick Bite Fever is next discussed, followed by Sylvatic and Murine
PrEPare for a PEP Talk
PrEPare for a PEP Talk May 4, 2026 00:40:46 Dr. Drew Wilson, ID Pharmacy Resident, discusses the new options for pre-exposure prophylaxis (PrEP) to prevent HIV infection. Options discussed include oral PrEP (Truvada, Descovy), cabotegravir, and a newer option, lenacapravir. A prescribing algorithm is also presented, and the topic of developing resistance is also covered. Lastly, Dr. Wilson touches upon other novel agents for PrEP, as well
IDMythbusters: Evaluating Historical and Current Practice Patterns
IDMythbusters: Evaluating Historical and Current Practice Patterns Apr 24, 2026 00:45:43 Parker Kaleo, PharmD, Pgy2 ID Pharmacy Resident, presents a review of several recent controversies in infectious diseases. He addresses the optimal therapy for refractory MSSA bacteremia, the use of “cidal” versus “bacteriostatic” antimicrobials for severe infections, oral cephalosporins as step down therapy for severe infections, the penetration of cefazolin for CNS infect
Diabetic Foot Infections Management for 2026
Diabetic Foot Infections Management for 2026 Apr 17, 2026 01:01:04 Dr. Richard L. Oehler, MD, Professor of Medicine at the USF Morsani College of Medicine, presents this update on Diabetic Foot Infections (DFIs) in 2026. Focusing on recent guidelines and scientific literature, Dr. Oeher discusses DFI epidemiology, pathophysiology, and Diabetic foot exam basics. He then goes on to review diabetic vascular disease and its role in the progression of diabetic foot co
Travel Medicine, Puerto Rico Edition
Travel Medicine, Puerto Rico Edition Apr 6, 2026 00:49:47 Dr. Cordero-Baez, MD, Infectious Diseases Fellow at the Morsani USF College of Medicine, presents a lighthearted (and Bad Bunny-inspired) look at travel medicine recommendations for Puerto Rico, a popular travel destination (and his home country) in the Caribbean. Dr. Cordero starts by taking a close look at Dengue, for which cases experienced a surge on the island as recently as in 2024. He then
Mechanisms of Gram Negative Resistance: Part II–Therapeutics
Mechanisms of Gram Negative Resistance: Part II–Therapeutics Mar 24, 2026 00:07:06 Dr. Mel O’Neal, Infectious Diseases pharmacist at Tampa General Hospital, presents part 2 of her series on Gram Negative Resistance, focusing on therapeutics for treatment of these resistant pathogens. Dr. O’Neal begins by identifying the main resistance mechanisms, including membrane porins, efflux pumps, drug binding site mutations, and degrading enzymes (e.g., beta-lactamases.) She

Recommended